Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
European Commission approves Oxbryta® (voxelotor) for the treatment of hemolytic anemia in patients with sickle cell disease age 12 years and older [Internet]. Global Blood Therapeutics, Inc.; [ ]. Available from: https://ir.gbt.com/news-releases/news-release-details/european-commission-approves-oxbrytar-voxelotor-treatment
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
